INS and metabolic dysfunction-associated steatotic liver disease: Additionally, IPA supplementation improves glucose metabolism, enhances insulin sensitivity, inhibits liver lipid synthesis and inflammation, and maintains intestinal homeostasis,[85] thereby potentially alleviating MASLD.